Eyileten, Ceren
Wicik, Zofia
Keshwani, Disha
Aziz, Faisal
Aberer, Felix
Pferschy, Peter N.
Tripolt, Norbert J.
Sourij, Caren
Prietl, Barbara
Prüller, Florian
von Lewinski, Dirk
De Rosa, Salvatore
Siller-Matula, Jolanta M.
Postula, Marek
Sourij, Harald
Clinical trials referenced in this document:
Documents that mention this clinical trial
Alteration of circulating platelet-related and diabetes-related microRNAs in individuals with type 2 diabetes mellitus: a stepwise hypoglycaemic clamp study
https://doi.org/10.1186/s12933-022-01517-5
Article History
Received: 20 February 2022
Accepted: 22 April 2022
First Online: 20 May 2022
Declarations
:
: The study was approved by the Ethics Committee of the Medical University of Graz, Austria, (Ethics Committee number: EK30-012 ex 17/18 for the main study and 33-515 ex 20/21 for the current analysis) and a written consent, for all study-related procedures, was given by all study participants. The study was conducted in accordance with the Declaration of Helsinki, as well as the guidelines laid down by the International Conference on Harmonization for Good Clinical Practice (ICH GCP E6 guidelines). Recruitment of the participants was performed with the use of a local recruitment registry (Graz Diabetes Registry for Biomarker Research, GIRO). The study was registered at clinical trials.gov (ExternalRef removed│NCT03460899).
: Not applicable.
: Authors declare no conflict of interest related to this work.